1996 - Member of the National Academy of Medicine (NAM)
Psychiatry, Addiction, Anesthesia, Methadone and Clinical psychology are his primary areas of study. His Psychiatry research is multidisciplinary, incorporating perspectives in Treatment outcome and Antisocial personality disorder. His research integrates issues of Internal medicine, Clinical trial, Research Diagnostic Criteria, Depression and Opiate in his study of Addiction.
His Anesthesia study combines topics in areas such as Placebo, Pharmacology and Naltrexone. His Methadone research integrates issues from Heroin, Craving and Opioid. His Clinical psychology research incorporates elements of Anxiety, Schizophrenia, Abstinence and Rating scale.
Herbert D. Kleber focuses on Psychiatry, Addiction, Anesthesia, Substance abuse and Opiate. Psychiatry is often connected to Clinical psychology in his work. The study incorporates disciplines such as Methadone, Endocrinology, Research Diagnostic Criteria, Depression and Internal medicine in addition to Addiction.
His Anesthesia research is multidisciplinary, relying on both Buprenorphine, Opioid, Naltrexone and Pharmacology. His Naltrexone research incorporates themes from Opioid antagonist and Heroin. His studies link Anxiety with Opiate.
Herbert D. Kleber mainly investigates Psychiatry, Anesthesia, Naltrexone, Buprenorphine and Heroin. His study explores the link between Psychiatry and topics such as Subjective effects that cross with problems in Pharmacological treatment and Nicotine. His Anesthesia research includes elements of Placebo, Narcotic antagonist, Discontinuation and Opioid.
The concepts of his Opioid study are interwoven with issues in Randomized controlled trial, Abstinence and Retrospective cohort study. Herbert D. Kleber interconnects Methadone, Addictive behavior and Internal medicine in the investigation of issues within Heroin. His Internal medicine research integrates issues from Cocaine dependence and Clinical psychology.
Herbert D. Kleber spends much of his time researching Anesthesia, Opioid, Heroin, Dopamine and Naltrexone. Herbert D. Kleber has included themes like Substance abuse, Substance dependence, Movement disorders and Outpatient clinic in his Anesthesia study. His Heroin study is associated with Psychiatry.
His Dopamine research is multidisciplinary, incorporating perspectives in Cocaine dependence and Neurotransmitter. Herbert D. Kleber focuses mostly in the field of Randomized controlled trial, narrowing it down to matters related to Oral administration and, in some cases, Addiction. His work deals with themes such as Adverse effect and Pharmacology, which intersect with Addiction.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Drug Dependence, a Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes Evaluation
A. Thomas McLellan;David C. Lewis;Herbert D. Kleber.
JAMA (2000)
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers: Clinical Observations
Frank H. Gawin;Herbert D. Kleber.
Archives of General Psychiatry (1986)
Heterogeneity of Psychiatric Diagnosis in Treated Opiate Addicts
Bruce J. Rounsaville;Myrna M. Weissman;Herbert Kleber;Charles Wilber.
Archives of General Psychiatry (1982)
Diagnosis and Symptoms of Depression in Opiate Addicts: Course and Relationship to Treatment Outcome
Bruce J. Rounsaville;Myrna M. Weissman;Katherine Crits-Christoph;Charles Wilber.
Archives of General Psychiatry (1982)
Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study.
Bruce J. Rounsaville;Thomas R. Kosten;Myrna M. Weissman;Herbert D. Kleber.
Archives of General Psychiatry (1986)
Desipramine facilitation of initial cocaine abstinence.
Frank H. Gawin;Herbert D. Kleber;Robert Byck;Bruce J. Rounsaville.
Archives of General Psychiatry (1989)
Can the national addiction treatment infrastructure support the public's demand for quality care?
A Thomas McLellan;Deni Carise;Herbert D Kleber.
Journal of Substance Abuse Treatment (2003)
Injectable, Sustained-Release Naltrexone for the Treatment of Opioid Dependence: A Randomized, Placebo-Controlled Trial
Sandra D. Comer;Maria A. Sullivan;Elmer Yu;Jami L. Rothenberg.
Archives of General Psychiatry (2006)
Opiate Withdrawal Using Clonidine: A Safe, Effective, and Rapid Nonopiate Treatment
M S Gold;A C Pottash;D R Sweeney;H D Kleber.
JAMA (1980)
Cocaine Abuse Treatment: Open Pilot Trial With Desipramine and Lithium Carbonate
Frank H. Gawin;Herbert D. Kleber.
Archives of General Psychiatry (1984)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Baylor College of Medicine
Yale University
Columbia University
Washington University in St. Louis
Icahn School of Medicine at Mount Sinai
Columbia University
Columbia University
University of Pennsylvania
Columbia University
University of Pennsylvania
Heinrich Heine University Düsseldorf
University of Maryland, College Park
University of Southampton
University of Strathclyde
Thermo Fisher Scientific (Israel)
University of Michigan–Ann Arbor
University of Otago
Newcastle University
Nara Institute of Science and Technology
University of California, San Francisco
Scripps Research Institute
University of Quebec
Bielefeld University
University of Washington
Mayo Clinic
University of Minnesota